Rokitamycin (TMS) does not elicit an immune response on its own. Specific antibodies against rokitamycin were only detected when it was chemically linked to a carrier protein, indicating its hapten nature.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: